What This Article Covers
Non-invasive prenatal DNA paternity testing (NIPPT) lets you check paternity before birth from a simple blood draw from the pregnant woman. The meaning of “accuracy,” however, depends on the assumptions each testing company uses, so it is risky to judge a test by a single number alone. This article explains how the test works, how to think about accuracy, the factors that can make a result inconclusive, and how the test differs from legally admissible paternity testing, drawing on information from public institutions.
- The difference between NIPPT (prenatal paternity testing) and NIPT (prenatal chromosomal screening)
- Why a maternal blood sample can be used to determine paternity non-invasively
- How to interpret “accuracy,” and what factors can keep a result from being conclusive
- The difference between private testing and legally admissible testing
- What to check before deciding on a test
What Is Prenatal DNA Paternity Testing (NIPPT)?
Prenatal DNA paternity testing (NIPPT) analyzes fragments of fetal-derived DNA circulating in a pregnant woman’s blood to determine, before birth, whether a man is the biological father. Unlike amniocentesis or chorionic villus sampling, it does not require inserting a needle into the uterus, so the burden on the mother is much smaller.
Don’t Confuse “NIPT” and “NIPPT”
The similar names cause frequent confusion, but the two tests serve completely different purposes. NIPT (Non-Invasive Prenatal Testing) is a screening test for possible fetal chromosomal conditions such as trisomy 21 (Down syndrome); it does not determine paternity. NIPPT (prenatal paternity testing), on the other hand, is a DNA profiling test that identifies the biological father — it has nothing to do with chromosomal conditions. Japan’s committee that oversees prenatal testing certification, operated under the Japanese Association of Medical Sciences, likewise describes NIPT as a screening test for chromosomal conditions, confirming that the two purposes are distinct. Before you start researching, it helps to be clear about which of the two tests you actually need.
How the Test Works and What Affects Accuracy
NIPPT accuracy depends on the type of sample collected and on how much of the DNA is analyzed, and in how much detail. Here is an overview of the basic testing process.
Sample Collection and the Earliest Testing Week
A typical NIPPT involves a blood draw from the pregnant woman herself, plus a buccal (inner cheek) swab from both the pregnant woman and the man being tested as the possible father. Hiro Clinic’s NIPPT accepts testing from 6 weeks of pregnancy — earlier than a standard NIPT (chromosomal screening test) — reflecting how often patients ask to learn the result as early as possible.
How STR Analysis Determines Paternity
Fetal-derived DNA fragments in maternal blood exist mixed together with the mother’s own DNA. The basic approach is to infer the fetal DNA profile from that mixture, then statistically evaluate the likelihood of a paternal relationship by comparing it with the profile of the man being tested. A few different analysis methods are used for this.
- STR (Short Tandem Repeat) analysis: a marker type long used in forensic science, comparing repeat-sequence patterns on the autosomes and Y chromosome.
- SNP (Single Nucleotide Polymorphism) analysis: a method that compares large numbers of single-base differences, also widely used in modern NIPT-related technology.
Hiro Clinic’s NIPPT uses targeted next-generation sequencing on the “MiSeq FGx System” sequencer. The analysis covers 27 autosomal STR loci (including the FBI’s 20 CODIS core loci), 25 Y-chromosome STR loci, and the Amelogenin gene used for sex determination. The manufacturer cites the larger number of markers as an accuracy advantage compared with methods that rely on only a small number of SNPs. That said, this is a technical claim made by the manufacturer, and no single method can be called categorically superior. When comparing providers, check the type and number of markers used and whether the analyzing laboratory holds third-party accreditation.
If you would like more technical detail, the following articles explain the testing kit and analysis equipment used.
How to Think About Accuracy (Without Overclaiming)
The accuracy of DNA profiling rests on a statistical concept: if a man is the biological father, the test returns a positive result with a very high probability, and if he is not, the result is denied. This does not mean the result is “guaranteed to be error-free.”
In general paternity testing practice, a probability of paternity is calculated by combining many DNA markers. In most real-world cases, paternity is affirmed with a probability well above 99.9%, or denied with a probability close to 0%. In our clinic, patients frequently ask about accuracy during consultations, and some assume that a high percentage means the result is “absolutely certain.” It is important to understand what the number actually represents before deciding.
Factors That Can Affect Accuracy
Even with the same testing method, the following factors can change how a result should be interpreted. Checking them beforehand is the surest path to peace of mind.
| Factor | Effect | What to check |
|---|---|---|
| Gestational week at blood draw / amount of fetal-derived DNA | A low fraction of fetal-derived DNA can make analysis more difficult | Whether you meet the recommended minimum gestational week |
| Multiple pregnancy (twins, triplets, etc.) | DNA from more than one fetus can be mixed, making individual determination difficult | Whether the provider supports multiple pregnancies — confirm in advance |
| Sample quality/quantity | An insufficient buccal sample may require re-collection | Follow the collection kit instructions correctly |
| More than one possible father | Determination can be difficult when the candidates are close genetic relatives | Consult the provider in advance if this applies to you |
These factors can occasionally lead to an “inconclusive” result requiring re-testing. There is no need for excessive worry, but it helps to go in understanding that some residual uncertainty is possible, rather than assuming the result will always be conclusive on the first attempt.
Benefits and Limits of a Non-Invasive Test
NIPPT’s biggest advantage is that it is non-invasive, placing little burden on the mother. Because there is no procedure that inserts a needle into the uterus, as with amniocentesis, you can check paternity while avoiding risks such as miscarriage.
Being non-invasive, however, is a separate matter from whether a result carries legal weight. As explained in the next section, a private test result generally cannot, by itself, be used in court or administrative procedures. Which type of test you should choose depends on whether your purpose is “confirming paternity privately within the family” or “using the result in a legal procedure such as a paternity mediation.”
Private Testing vs. Legally Admissible Testing
Even though both are DNA paternity tests, “private testing” and “legally admissible testing” differ completely in how the sample is collected and how the result can be used. Choosing a test that doesn’t match your purpose can leave you unable to use the result for a legal procedure later on.
| Item | Private testing | Legally admissible testing |
|---|---|---|
| Sample collection | Often self-collected at home | Collected at a designated facility, with identity verification and a witness present |
| Identity verification | Often not strictly verified | Photo ID verification is mandatory |
| Record keeping | No specific requirements | Chain of custody is recorded and maintained |
| Use of the result | Mainly for private, family peace-of-mind purposes | Admissible in court and administrative procedures |
In family court proceedings involving paternity recognition, the court may order a DNA test as part of its fact-finding. Japan’s courts publish guidance explaining these family-law procedures. In addition, the legal rule that determines who is presumed by law to be the father of a child born during marriage — the “presumption of legitimacy” system — was revised in April 2024 (Reiwa 6), allowing operation more in line with real-world circumstances than before. Because the legal treatment of paternity is closely tied to Japan’s Civil Code, if you anticipate court or family-register procedures, choose legally admissible testing rather than private testing, and consult a lawyer or the family court in advance.
What to Check Before Choosing a Test
When choosing a testing provider, the transparency of the testing process matters more for peace of mind than the accuracy figure by itself. Here are the points worth checking.
Whether the analyzing laboratory holds third-party accreditation such as ISO/IEC 17025 is one useful gauge of its quality-management system; the Japan Accreditation Board (JAB) publishes information on this type of laboratory accreditation. Hiro Clinic’s NIPPT is analyzed at a domestic testing institution in Japan (Tokyo Health Inspection Center) that operates multiple next-generation sequencers, in partnership with the clinic. We also see a fair number of patients who come in with concerns beyond accuracy — how to discuss the result with a partner, for instance. Checking the support available after the test, not just the accuracy figure, can help you approach testing with greater confidence.
Conclusion: Choose Based on Purpose, Not the Accuracy Number Alone
Prenatal DNA paternity testing (NIPPT) lets you determine paternity before birth with little burden on the mother, but what an accuracy figure actually means depends on the testing method and its underlying assumptions. Start by clarifying the difference from NIPT (chromosomal screening), decide whether your purpose is private confirmation or a legal procedure, and then check the provider’s analysis process and whether it holds third-party accreditation. Understanding in advance that a result can occasionally be inconclusive, and that private and legal tests carry different legal weight, will help you respond calmly once the result arrives. If in doubt, consult not only the testing provider but also a lawyer or the family court whenever a legal procedure may be involved.
Frequently Asked Questions
Here are answers to questions we are commonly asked about prenatal DNA paternity testing.
From what week of pregnancy can I take the test?
Hiro Clinic’s NIPPT accepts testing from 6 weeks of pregnancy. The earliest available week varies by provider, so confirm this in advance.
How accurate is the test?
In general DNA profiling, if the man tested is the biological father, the result is affirmed with a very high probability; if not, the probability becomes extremely low. The specific figures vary with the testing method and sample condition, so avoid judging by an extremely high number alone and check the analysis process as well.
Is there any burden on the mother or baby?
Because only a blood draw is required, the burden on the mother is considered smaller than with a procedure that inserts a needle into the uterus, such as amniocentesis or chorionic villus sampling. If you have any health concerns, consult your doctor before testing.
Can I use the result in court?
A private test result generally carries no legal weight on its own. If you need to use it in court or an administrative procedure, you must choose a legally admissible test, which involves strict identity verification and chain-of-custody sample handling.
How is this different from NIPT?
NIPT is a screening test for possible fetal chromosomal conditions such as trisomy 21; it does not determine paternity. NIPPT (prenatal paternity testing) is a DNA profiling test that determines paternity itself — the two serve different purposes.
Can I take the test with a multiple pregnancy, such as twins?
With a multiple pregnancy, DNA from more than one fetus can be mixed together, which may make individual determination difficult. If this applies to you, always confirm with the provider whether it can be supported before applying.
Can the result come back inconclusive?
Depending on sample volume and the proportion of fetal-derived DNA, a result can rarely come back inconclusive and require re-testing. Please understand this possibility before deciding to test — a conclusive result on the first attempt is not guaranteed.
Medical supervision: Dr. Hiroshi Oka — Director-General and Lab Director, Hiro Clinic (operated by Fukumikai Medical Corporation). Graduate of Keio University School of Medicine. Passed the medical licensing examinations in both Japan and the United States, and earned his medical doctorate within two years of completing clinical training. He holds a Lab Director qualification, held by only a small number of people in Japan. Author of a guidebook for expectant parents. This article is prepared with attention to Japan’s medical advertising guidelines and references information from public institutions and academic bodies. Private NIPPT results carry no legal weight; if you are considering a legal procedure, please consult a lawyer or the family court.
References (Japanese): Japanese Association of Medical Sciences, Committee on Certification of Prenatal Testing, “What Is NIPT (Non-Invasive Prenatal Genetic Testing)” / Courts in Japan, “Family Court Proceedings Q&A” / Ministry of Justice, “Amendment to the Civil Code (Revision of the Presumption of Legitimacy System)” / Japan Accreditation Board (JAB), “Testing and Calibration Laboratories (ISO/IEC 17025)”
日本皮膚科学会 皮膚科専門医／日本医師会 産業医／東京衛生検査所 指導監督医
この記事は、 ヒロクリニックNIPTの編集・監修体制 にもとづき、資格を持つ医師が内容を確認しています。
